Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Böwe Systec International and Strålfors in joint venture
Mandate

Böwe Systec International and Strålfors in joint venture

May 12, 2005

Roll Systems Inc., the US based manufacturer of paper handling, converting and monitoring systems for digital printers, and the Lasermax division, a business that supplies paper handling equipment for digital printers, have combined in a 50:50 joint venture to form Lasermax Roll Systems AB, in a transaction valued at approximately USD 44m. Roll Systems Inc. is a subsidiary of Böwe Systec International Gmbh, the German supplier of paper management systems for high volume mail processing and the Lasermax is a division of Strålfors, the Sweden based provider of information transfer solutions

Vinge acted for Böwe Systec International GmbG.
Jan Örtenholm (reponsible partner)
Jesper Ottergren, Emma Olnäs, Anna Jonsson, Magnus Larsson, Environmental law, and Maria Strömhage, Employment Law (associates)

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025